Bioceres Crop Solutions Corp
(BIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,845 | 7,289 | 20,175 | -3,909 | -3,821 |
| Depreciation Amortization | 22,182 | 21,295 | 19,391 | 9,188 | 6,265 |
| Accounts receivable | 25,499 | -46,681 | -56,867 | -24,971 | 1,987 |
| Accounts payable and accrued liabilities | -32,039 | 14,234 | -4,501 | 53,477 | -5,832 |
| Other Working Capital | 19,421 | -38,763 | -79,728 | -55,223 | -50,903 |
| Other Operating Activity | 73,688 | 84,343 | 104,121 | 3,922 | 46,098 |
| Operating Cash Flow | $49,906 | $41,717 | $2,589 | $-17,515 | $-6,206 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -102 |
| PPE Investments | -5,252 | -9,453 | -11,223 | -1,412 | -2,496 |
| Net Acquisitions | N/A | 38 | 4,373 | N/A | 356 |
| Purchase Of Investment | -11,182 | -7,208 | -8,990 | -2,056 | -4,275 |
| Sale Of Investment | 19,270 | 888 | 1,317 | 12,331 | 9,324 |
| Purchase Sale Intangibles | -351 | -1,137 | -450 | -389 | -7,211 |
| Other Investing Activity | -8,965 | -12,993 | -11,203 | -5,960 | -11,117 |
| Investing Cash Flow | $-6,129 | $-28,728 | $-25,726 | $2,903 | $-8,310 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -3,443 |
| Debt Issued | 266,390 | 135,818 | 79,818 | 140,431 | 143,499 |
| Debt Repayment | -288,454 | -112,614 | -16,745 | -110,625 | -126,024 |
| Common Stock Repurchased | -927 | -734 | -2,997 | N/A | -3,500 |
| Dividend Paid | -72 | -175 | -452 | N/A | N/A |
| Other Financing Activity | -27,643 | -32,351 | -26,670 | -14,982 | -3,175 |
| Financing Cash Flow | $-50,706 | $-10,056 | $32,954 | $14,824 | $7,358 |
| Exchange Rate Effect | -4,851 | -6,557 | 4,939 | 6,843 | 6,265 |
| Beginning Cash Position | 44,473 | 48,129 | 33,475 | 36,046 | 42,523 |
| End Cash Position | 32,695 | 44,473 | 48,129 | 33,475 | 36,046 |
| Net Cash Flow | $-11,778 | $-3,656 | $14,654 | $-2,571 | $-6,477 |
| Free Cash Flow | |||||
| Operating Cash Flow | 49,906 | 41,717 | 2,589 | -17,515 | -6,206 |
| Capital Expenditure | -5,642 | -9,790 | -11,361 | -3,459 | -2,806 |
| Free Cash Flow | 44,263 | 31,927 | -8,772 | -20,974 | -9,012 |